SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 487,000 Value ($000) $10,232 Avg Close $17.45 Range $12.99 - $22.73
Q3 2025
Shares 574,000 Value ($000) $8,831 Avg Close $13.09 Range $8.59 - $17.24
Q2 2025
Shares 574,000 Value ($000) $5,376 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 433,000 Value ($000) $5,319 Avg Close $14.10 Range $12.06 - $16.95
Q4 2024
Shares 232,000 Value ($000) $3,067 Avg Close $17.11 Range $12.40 - $22.50
Q3 2024
Shares 259,500 Value ($000) $4,995 Avg Close $20.66 Range $17.34 - $25.07
Q2 2024
Shares 228,500 Value ($000) $4,691 Avg Close $20.93 Range $18.65 - $24.38
Q1 2024
Shares 178,500 Value ($000) $4,248 Avg Close $22.30 Range $19.58 - $25.34